Hydroxyurea-induced amyopathic dermatomyositis presenting with heliotrope erythema

Eri Ito; Yoshinao Muro; Akitaka Shibata; Kazumitsu Sugiura; Masashi Akiyama

Hydroxyurea-induced amyopathic dermatomyositis presenting with heliotrope erythema

Eri Ito, Yoshinao Muro, Akitaka Shibata, Kazumitsu Sugiura, Masashi Akiyama

Research output: Contribution to journal › Article › peer-review

Abstract

Hydroxyurea (HU) is a chemotherapeutic agent used for the treatment of myeloproliferative disorders such as chronic myeloid leukemia, polycythemia vera, and essential thrombocytosis. We describe a 69-year-old man who had essential thrombocytosis and developed amyopathic dermatomyositis after long-term HU therapy. He presented with Gottron papules and heliotrope erythema. The former has been described in all cases of HU-induced dermatomyositis; the latter has been seen in a few cases of that disorder.

Original language	English
Journal	Dermatology Online Journal
Volume	20
Issue number	8
Publication status	Published - 2014
Externally published	Yes

All Science Journal Classification (ASJC) codes

Dermatology

Cite this

@article{a9e9d824b9bc4590bbcc0b4bfc4ea433,

title = "Hydroxyurea-induced amyopathic dermatomyositis presenting with heliotrope erythema",

abstract = "Hydroxyurea (HU) is a chemotherapeutic agent used for the treatment of myeloproliferative disorders such as chronic myeloid leukemia, polycythemia vera, and essential thrombocytosis. We describe a 69-year-old man who had essential thrombocytosis and developed amyopathic dermatomyositis after long-term HU therapy. He presented with Gottron papules and heliotrope erythema. The former has been described in all cases of HU-induced dermatomyositis; the latter has been seen in a few cases of that disorder.",

author = "Eri Ito and Yoshinao Muro and Akitaka Shibata and Kazumitsu Sugiura and Masashi Akiyama",

year = "2014",

language = "English",

volume = "20",

journal = "Dermatology Online Journal",

issn = "1087-2108",

publisher = "Dermatology Online Journal",

number = "8",

}

TY - JOUR

T1 - Hydroxyurea-induced amyopathic dermatomyositis presenting with heliotrope erythema

AU - Ito, Eri

AU - Muro, Yoshinao

AU - Shibata, Akitaka

AU - Sugiura, Kazumitsu

AU - Akiyama, Masashi

PY - 2014

Y1 - 2014

N2 - Hydroxyurea (HU) is a chemotherapeutic agent used for the treatment of myeloproliferative disorders such as chronic myeloid leukemia, polycythemia vera, and essential thrombocytosis. We describe a 69-year-old man who had essential thrombocytosis and developed amyopathic dermatomyositis after long-term HU therapy. He presented with Gottron papules and heliotrope erythema. The former has been described in all cases of HU-induced dermatomyositis; the latter has been seen in a few cases of that disorder.

AB - Hydroxyurea (HU) is a chemotherapeutic agent used for the treatment of myeloproliferative disorders such as chronic myeloid leukemia, polycythemia vera, and essential thrombocytosis. We describe a 69-year-old man who had essential thrombocytosis and developed amyopathic dermatomyositis after long-term HU therapy. He presented with Gottron papules and heliotrope erythema. The former has been described in all cases of HU-induced dermatomyositis; the latter has been seen in a few cases of that disorder.

UR - https://www.scopus.com/pages/publications/84906215139

UR - https://www.scopus.com/inward/citedby.url?scp=84906215139&partnerID=8YFLogxK

M3 - Article

C2 - 25148281

AN - SCOPUS:84906215139

SN - 1087-2108

VL - 20

JO - Dermatology Online Journal

JF - Dermatology Online Journal

IS - 8

ER -

Hydroxyurea-induced amyopathic dermatomyositis presenting with heliotrope erythema

Abstract

All Science Journal Classification (ASJC) codes

Other files and links

Fingerprint

Cite this